Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sgx Pharmaceuticals, Inc. (SGXP) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Sgx Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1125603.
Total stock buying since 2006: $6,141,713.
Total stock sales since 2006: $198,954.
Total stock option exercises since 2006: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 2,403,357 | $5,541,713 | 14,058 | $41,483 | 28,126 | $0 |
| 2007 | 0 | $0 | 27,338 | $129,440 | 54,687 | $0 |
| 2006 | 100,000 | $600,000 | 9,375 | $28,031 | 18,750 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-08 | 0 | $0 | 1,562 | $4,638 | 3,125 | $0 |
| 2008-07 | 1,298,100 | $3,939,091 | 1,562 | $3,634 | 3,125 | $0 |
| 2008-06 | 1,105,257 | $1,602,622 | 1,562 | $2,342 | 3,125 | $0 |
| 2008-05 | 0 | $0 | 1,562 | $2,248 | 3,125 | $0 |
| 2008-04 | 0 | $0 | 1,562 | $1,977 | 3,125 | $0 |
| 2008-03 | 0 | $0 | 3,124 | $12,556 | 6,251 | $0 |
| 2008-02 | 0 | $0 | 1,562 | $6,599 | 3,125 | $0 |
| 2008-01 | 0 | $0 | 1,562 | $7,489 | 3,125 | $0 |
| 2007-12 | 0 | $0 | 1,562 | $7,496 | 3,125 | $0 |
| 2007-11 | 0 | $0 | 1,562 | $9,059 | 3,125 | $0 |
| 2007-10 | 0 | $0 | 1,562 | $9,856 | 3,125 | $0 |
| 2007-09 | 0 | $0 | 1,562 | $9,631 | 3,125 | $0 |
| 2007-08 | 0 | $0 | 1,562 | $10,195 | 3,125 | $0 |
| 2007-07 | 0 | $0 | 1,562 | $8,887 | 3,125 | $0 |
| 2007-06 | 0 | $0 | 1,562 | $8,158 | 3,125 | $0 |
| 2007-05 | 0 | $0 | 1,562 | $7,985 | 3,125 | $0 |
| 2007-04 | 0 | $0 | 1,562 | $7,522 | 3,125 | $0 |
| 2007-03 | 0 | $0 | 1,562 | $8,090 | 3,125 | $0 |
| 2007-02 | 0 | $0 | 1,562 | $7,231 | 3,125 | $0 |
| 2007-01 | 0 | $0 | 10,156 | $35,330 | 20,312 | $0 |
| 2006-12 | 0 | $0 | 9,375 | $28,031 | 18,750 | $0 |
| 2006-02 | 100,000 | $600,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-08-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 2.98 | 2,327 |
| 2008-08-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2008-08-05 | Myers W Todd (CFO) | Sale | 781 | 2.96 | 2,311 |
| 2008-08-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2008-07-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 3.06 | 2,385 |
| 2008-07-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2008-07-11 | Bvf Inc/il (Other) | Buy | 12,500 | 3.07 | 38,362 |
| 2008-07-10 | Bvf Inc/il (Other) | Buy | 403,200 | 3.03 | 1,221,292 |
| 2008-07-09 | Bvf Inc/il (Other) | Buy | 800,300 | 3.04 | 2,433,712 |
| 2008-07-08 | Bvf Inc/il (Other) | Buy | 82,100 | 2.99 | 245,725 |
| 2008-07-07 | Myers W Todd (CFO) | Sale | 781 | 1.60 | 1,249 |
| 2008-07-07 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2008-06-18 | Bvf Inc/il (Other) | Buy | 1,105,257 | 1.45 | 1,602,622 |
| 2008-06-16 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 1.65 | 1,288 |
| 2008-06-16 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2008-06-05 | Myers W Todd (CFO) | Sale | 781 | 1.35 | 1,054 |
| 2008-06-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2008-05-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 1.45 | 1,132 |
| 2008-05-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2008-05-05 | Myers W Todd (CFO) | Sale | 781 | 1.43 | 1,116 |
| 2008-05-05 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2008-04-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 1.19 | 929 |
| 2008-04-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2008-04-07 | Myers W Todd (CFO) | Sale | 781 | 1.34 | 1,048 |
| 2008-04-07 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2008-03-17 | Reich Siegfried (VP, Drug Discovery) | Sale | 1,562 | 4.01 | 6,262 |
| 2008-03-17 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 3,126 | .00 | 0 |
| 2008-03-05 | Myers W Todd (CFO) | Sale | 781 | 4.05 | 3,163 |
| 2008-03-05 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2008-02-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 4.05 | 3,163 |
| 2008-02-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2008-02-05 | Myers W Todd (CFO) | Sale | 781 | 4.40 | 3,436 |
| 2008-02-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2008-01-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 4.44 | 3,467 |
| 2008-01-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2008-01-07 | Myers W Todd (CFO) | Sale | 781 | 5.15 | 4,022 |
| 2008-01-07 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2007-12-17 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 4.75 | 3,709 |
| 2007-12-17 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2007-12-05 | Myers W Todd (CFO) | Sale | 781 | 4.85 | 3,787 |
| 2007-12-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2007-11-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.10 | 3,983 |
| 2007-11-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2007-11-05 | Myers W Todd (CFO) | Sale | 781 | 6.50 | 5,076 |
| 2007-11-05 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2007-10-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.42 | 5,014 |
| 2007-10-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2007-10-05 | Myers W Todd (CFO) | Sale | 781 | 6.20 | 4,842 |
| 2007-10-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2007-09-17 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.20 | 4,842 |
| 2007-09-17 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2007-09-05 | Myers W Todd (CFO) | Sale | 781 | 6.13 | 4,789 |
| 2007-09-05 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2007-08-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.42 | 5,017 |
| 2007-08-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2007-08-06 | Myers W Todd (CFO) | Sale | 781 | 6.63 | 5,178 |
| 2007-08-06 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2007-07-16 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.05 | 4,725 |
| 2007-07-16 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2007-07-05 | Myers W Todd (CFO) | Sale | 781 | 5.33 | 4,162 |
| 2007-07-05 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2007-06-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.15 | 4,019 |
| 2007-06-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2007-06-05 | Myers W Todd (CFO) | Sale | 781 | 5.30 | 4,139 |
| 2007-06-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2007-05-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.18 | 4,049 |
| 2007-05-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2007-05-07 | Myers W Todd (CFO) | Sale | 781 | 5.04 | 3,936 |
| 2007-05-05 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2007-04-16 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.02 | 3,922 |
| 2007-04-16 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2007-04-05 | Myers W Todd (CFO) | Sale | 781 | 4.61 | 3,600 |
| 2007-04-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2007-03-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.53 | 4,318 |
| 2007-03-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,563 | .00 | 0 |
| 2007-03-05 | Myers W Todd (CFO) | Sale | 781 | 4.83 | 3,772 |
| 2007-03-05 | Myers W Todd (CFO) | Option Ex | 1,562 | .00 | 0 |
| 2007-02-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.36 | 4,186 |
| 2007-02-15 | Reich Siegfried (VP, Drug Discovery) | Option Ex | 1,562 | .00 | 0 |
| 2007-02-05 | Myers W Todd (CFO) | Sale | 781 | 3.90 | 3,045 |
| 2007-02-05 | Myers W Todd (CFO) | Option Ex | 1,563 | .00 | 0 |
| 2007-01-16 | Reich Siegfried (Vice President, Drug Discovery) | Sale | 9,375 | 3.50 | 32,812 |
| 2007-01-16 | Reich Siegfried (Vice President, Drug Discovery) | Option Ex | 18,750 | .00 | 0 |
| 2007-01-05 | Myers W Todd (Chief Financial Officer) | Sale | 781 | 3.23 | 2,518 |
| 2007-01-05 | Myers W Todd (Chief Financial Officer) | Option Ex | 1,562 | .00 | 0 |
| 2006-12-05 | Myers W Todd (Chief Financial Officer) | Sale | 9,375 | 2.99 | 28,031 |
| 2006-12-05 | Myers W Todd (Chief Financial Officer) | Option Ex | 18,750 | .00 | 0 |
| 2006-02-06 | Lathi Vijay K (Director) | Buy | 100,000 | 6.00 | 600,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sgx Pharmaceuticals, Inc. (symbol SGXP, CIK number 1125603) see the Securities and Exchange Commission (SEC) website.